🇺🇸 FDA
Patent

US 7070934

Ligand-controlled regulation of endogenous gene expression

granted A61KA61K31/57

Quick answer

US patent 7070934 (Ligand-controlled regulation of endogenous gene expression) held by Sangamo Biosciences, Inc. expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/57